Mounjaro vs Ozempic: Which Is Right for You?

If you’re exploring medical weight loss options, chances are you’ve come across two names that dominate the conversation: Mounjaro (tirzepatide) and Ozempic (semaglutide). Both medications belong to a revolutionary class of drugs called GLP-1 receptor agonists, and both have demonstrated remarkable results in helping patients achieve significant, sustained weight loss. But they are not identical — and the right choice for you depends on your unique health profile, weight loss goals, and medical history.

At Femme Aesthetics & Health in Miami, our medical providers — led by Idelsis Trelles, PA-C — work closely with each patient to determine which medication offers the best path forward. In this comprehensive guide, we’ll walk you through everything you need to know about Mounjaro vs Ozempic so you can make a confident, informed decision about your weight loss journey.

Understanding GLP-1 Medications for Weight Loss

Before comparing these two medications head to head, it’s important to understand the class of drugs they belong to and why they’ve become so transformative for patients struggling with excess weight.

GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists) are a class of injectable medications originally developed to treat type 2 diabetes. They work by mimicking the action of a naturally occurring hormone called GLP-1, which your body produces in response to food intake. GLP-1 plays several key roles in metabolism:

• Appetite regulation: GLP-1 signals the brain’s satiety centers, helping you feel full sooner and reducing overall food intake. Many patients describe a noticeable decrease in food cravings and a diminished interest in overeating.
• Insulin sensitivity: These medications enhance the way your body produces and uses insulin, improving blood sugar control. This is particularly beneficial for patients with insulin resistance or prediabetes.
• Gastric emptying: GLP-1 receptor agonists slow the rate at which food moves through the stomach, extending the feeling of fullness after meals and reducing the urge to snack between meals.

The FDA has approved several GLP-1 receptor agonists for weight management in adults with a body mass index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity such as high blood pressure, type 2 diabetes, or high cholesterol. These approvals have opened the door for millions of patients who previously had limited options beyond diet and exercise alone.

At Femme Aesthetics, our medical weight loss program incorporates these medications as part of a holistic, provider-supervised approach that also addresses nutrition, lifestyle factors, and complementary treatments to maximize your results.

Mounjaro (Tirzepatide): How It Works

Mounjaro, the brand name for tirzepatide, is manufactured by Eli Lilly and Company. What sets Mounjaro apart from other weight loss medications is its dual-action mechanism — it is the first and only FDA-approved medication that acts as both a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist.

This dual incretin pathway approach means Mounjaro activates two different hormonal pathways simultaneously:

• GLP-1 pathway: Reduces appetite, slows gastric emptying, and improves insulin secretion — the same mechanism used by Ozempic and similar medications.
• GIP pathway: Enhances the body’s ability to process and store energy from food, improves fat metabolism, and may further amplify the appetite-suppressing effects of GLP-1 activation.

The result of this dual action is what researchers believe contributes to Mounjaro’s superior weight loss efficacy compared to single-action GLP-1 medications. By targeting two incretin receptors instead of one, tirzepatide appears to produce a more powerful metabolic effect.

Mounjaro was initially FDA-approved for the treatment of type 2 diabetes in 2022. Since then, it has gained widespread use for weight loss, and its weight-management-specific version — branded as Zepbound — received FDA approval for chronic weight management in November 2023.

Available doses: Mounjaro is administered as a once-weekly subcutaneous injection. Treatment typically begins at 2.5 mg per week and is gradually titrated upward over several months. The available doses are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg (the maximum dose). Your medical provider will adjust your dosage based on your response to the medication and any side effects you experience.

Ozempic (Semaglutide): How It Works

Ozempic is the brand name for semaglutide, manufactured by Novo Nordisk. Unlike Mounjaro’s dual-action approach, Ozempic works exclusively as a GLP-1 receptor agonist, targeting a single incretin pathway to achieve its effects.

Semaglutide binds to GLP-1 receptors in the brain, pancreas, and gut to:

• Suppress appetite by activating satiety centers in the hypothalamus
• Slow gastric emptying to prolong feelings of fullness
• Improve insulin secretion in a glucose-dependent manner, meaning it helps your body produce insulin when blood sugar is elevated without causing dangerous drops when blood sugar is normal
• Reduce glucagon secretion, which helps lower blood sugar levels after meals

Ozempic was FDA-approved for the treatment of type 2 diabetes in 2017. For patients seeking weight loss specifically, Novo Nordisk developed Wegovy — a higher-dose formulation of semaglutide (up to 2.4 mg weekly) that received FDA approval for chronic weight management in June 2021. While Ozempic and Wegovy contain the same active ingredient, they are prescribed for different indications and at different dosage ranges.

Available doses: Ozempic is also a once-weekly subcutaneous injection. For diabetes management, it starts at 0.25 mg and titrates up to 1 mg or 2 mg. For weight loss (as Wegovy), the titration schedule starts at 0.25 mg and increases over 16 to 20 weeks to the maintenance dose of 2.4 mg.

For a deeper scientific comparison of the active ingredients in these two medications, read our detailed guide on tirzepatide vs semaglutide.

Mounjaro vs Ozempic: Head-to-Head Comparison

Now that you understand how each medication works individually, let’s compare them across the factors that matter most to patients considering medical weight loss.

Weight Loss Efficacy

This is the area where the differences between Mounjaro and Ozempic are most pronounced — and where Mounjaro has a clear clinical advantage.

The landmark SURMOUNT clinical trial program studied tirzepatide (Mounjaro/Zepbound) across thousands of participants. The SURMOUNT-1 trial, which enrolled adults with obesity or overweight with at least one weight-related comorbidity, produced striking results:

• Participants taking the highest dose of tirzepatide (15 mg) lost an average of 22.5% of their body weight over 72 weeks.
• Even the lowest dose (5 mg) produced an average weight loss of approximately 15% of body weight.
• More than one-third of participants in the highest-dose group lost 25% or more of their body weight — a result that approaches what was previously only achievable through bariatric surgery.

By comparison, the STEP clinical trial program for semaglutide (Ozempic/Wegovy) also demonstrated impressive but somewhat lower weight loss results:

• In the STEP-1 trial, participants taking semaglutide 2.4 mg lost an average of approximately 14.9% of their body weight over 68 weeks.
• About one-third of participants lost 20% or more of their body weight.

While both results are clinically significant and life-changing for many patients, the data consistently shows that tirzepatide (Mounjaro) produces greater average weight loss than semaglutide (Ozempic) across comparable timeframes and patient populations. This advantage is widely attributed to Mounjaro’s dual GIP/GLP-1 mechanism of action.

That said, it’s essential to understand that real-world results may vary. Individual factors — including genetics, baseline weight, adherence to the medication, dietary habits, physical activity levels, and metabolic health — all influence how much weight a given patient will lose. Some patients respond better to semaglutide, while others see superior results with tirzepatide. This is exactly why a personalized clinical evaluation is so important.

Dosing and Administration

Both Mounjaro and Ozempic share a similar administration profile, which makes them equally convenient from a practical standpoint:

• Frequency: Both are administered as once-weekly subcutaneous injections, typically in the abdomen, thigh, or upper arm.
• Injection device: Both come in pre-filled, single-use injection pens with fine needles designed for patient self-administration at home. Most patients find the injection process quick, straightforward, and relatively painless.
• Dose titration: Both medications follow a gradual dose-escalation schedule to minimize side effects and allow your body to adjust.

The key differences in dosing are as follows:

• Mounjaro: Starts at 2.5 mg weekly. The dose is increased in increments every four weeks (2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg) based on tolerability and clinical response.
• Ozempic/Wegovy: Starts at 0.25 mg weekly. For weight loss, the dose increases monthly (0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg) to reach the therapeutic maintenance dose.

Your medical provider at Femme Aesthetics will carefully monitor your progress and adjust your dosing schedule to ensure you’re achieving optimal results with minimal side effects.

Side Effects Comparison

Because Mounjaro and Ozempic work through similar biological pathways, they share a largely overlapping side effect profile. The most commonly reported side effects for both medications are gastrointestinal in nature:

• Nausea — the most frequently reported side effect, particularly during the initial weeks and following dose increases
• Vomiting
• Diarrhea
• Constipation
• Abdominal discomfort or bloating
• Decreased appetite (which is partly the intended therapeutic effect)

The important thing to understand about these side effects is that they are generally mild to moderate in severity and tend to improve significantly over time as your body adjusts to the medication. The gradual dose-titration schedule is specifically designed to minimize these effects — which is why it’s critical to follow your medical provider’s recommended titration plan rather than attempting to increase your dose too quickly.

Less common side effects may include injection site reactions, fatigue, headache, and changes in taste. Serious side effects are rare but can include pancreatitis, gallbladder problems, and allergic reactions. Both medications carry a boxed warning about the potential risk of thyroid C-cell tumors based on animal studies, though this risk has not been confirmed in humans.

The importance of medical supervision cannot be overstated. At Femme Aesthetics, our medical providers monitor your progress through regular follow-up appointments, adjusting your treatment plan as needed to manage any side effects and ensure your safety throughout the process.

Cost and Insurance Coverage

Cost is one of the most significant practical considerations when choosing between Mounjaro and Ozempic. Both medications carry substantial list prices:

• Mounjaro/Zepbound: The retail price without insurance can range from approximately $1,000 to $1,200 per month.
• Ozempic/Wegovy: Similarly priced, with out-of-pocket costs typically ranging from $900 to $1,350 per month without insurance coverage.

Insurance coverage for these medications varies widely. Some plans cover semaglutide or tirzepatide for diabetes management but not for weight loss. Others may cover the weight-loss-specific formulations (Wegovy or Zepbound) if the patient meets certain BMI and comorbidity criteria. We encourage patients to check with their insurance provider before starting treatment.

At Femme Aesthetics, we strive to make medical weight loss accessible to as many patients as possible. Visit our pricing page for transparent information about consultation and treatment costs, and explore our Cherry payment plans for flexible financing options that can make these life-changing medications more affordable.

Which Medication Is Right for You?

Choosing between Mounjaro and Ozempic is not a one-size-fits-all decision. The right medication for you depends on a combination of clinical and personal factors, including:

• Medical history: Do you have type 2 diabetes, prediabetes, or insulin resistance? Are there any contraindications in your health profile that might make one medication more suitable than the other?
• Weight loss goals: How much weight do you need to lose? Patients with higher weight loss targets may benefit from Mounjaro’s potentially greater efficacy, while Ozempic may be an excellent choice for those with more moderate goals.
• Tolerance and side effects: Every patient’s body responds differently. Some patients tolerate tirzepatide better than semaglutide, and vice versa. If you’ve tried one medication and experienced intolerable side effects, switching to the other may be a viable option.
• Insurance coverage and cost: Practical financial considerations often play a role in medication selection. Your medical provider can help you navigate coverage options and identify the most cost-effective path.
• Previous medication experience: If you’ve already tried one of these medications with limited success, your medical provider may recommend switching to the other to see if you respond better to a different mechanism of action.

The most important step you can take is to undergo a comprehensive medical evaluation with a qualified medical provider who specializes in medical weight loss. At Femme Aesthetics, Idelsis Trelles, PA-C, and our clinical team take the time to review your complete health history, assess your metabolic markers, discuss your goals, and develop a personalized treatment plan tailored specifically to you.

“There is no single ‘best’ weight loss medication for everyone. The best medication is the one that aligns with your body’s unique needs, your health goals, and your lifestyle. Our job as medical providers is to evaluate the full picture and guide each patient toward the approach that will give them the safest, most sustainable results.”

— Idelsis Trelles, PA-C, Femme Aesthetics & Health

Medical Weight Loss at Femme Aesthetics

Our medical weight loss program at Femme Aesthetics is designed to provide the kind of comprehensive, provider-supervised care that produces lasting results. We don’t just write prescriptions — we partner with you throughout your entire weight loss journey.

Here’s what sets our program apart:

• Thorough initial evaluation: Your journey begins with an in-depth consultation where your medical provider reviews your medical history, current medications, laboratory work, body composition, and weight loss goals. This evaluation ensures that any medication we prescribe is safe and appropriate for your specific situation.
• Provider-supervised approach: Unlike online-only services or telehealth-only providers, our patients have access to in-person care from experienced medical providers who can perform physical examinations, order and interpret lab work, and make real-time adjustments to treatment plans.
• Regular monitoring and dosage adjustments: We schedule regular follow-up appointments to track your progress, assess side effects, and titrate your medication dosage as needed. This hands-on approach minimizes risks and maximizes results.
• Lifestyle and nutrition guidance: Medications are most effective when paired with sustainable lifestyle changes. Our team provides guidance on nutrition, physical activity, and behavioral strategies to help you build habits that support long-term weight maintenance.
• Integrated care: As a full-service medical aesthetics practice, we can address the cosmetic aspects of your weight loss journey as well — from skin tightening to body contouring — so you feel as good as you look at every stage.

Ready to find out which medication is right for you? Book your consultation today and take the first step toward a healthier, more confident you.

Complementary Treatments for Your Weight Loss Journey

Significant weight loss is a tremendous achievement, but it can sometimes bring cosmetic concerns — such as loose skin, loss of facial volume, or stubborn areas of fat that don’t resolve with weight loss alone. At Femme Aesthetics, we offer a range of complementary treatments that work beautifully alongside your medical weight loss program:

• Hormone therapy for metabolic support: Hormonal imbalances can significantly impact your ability to lose weight and maintain your results. Our EVEXIAS hormone therapy program uses bioidentical hormone replacement to optimize your hormonal balance, support a healthy metabolism, improve energy levels, and enhance overall well-being during your weight loss journey.
• Body contouring: For patients who have reached or are approaching their goal weight but still have areas of stubborn fat or skin laxity, treatments like Kybella (for submental fat reduction) and Sculptra (for volume restoration) can help refine your results and improve body contour.
• Skin tightening during weight loss: Morpheus8, our advanced RF microneedling treatment, stimulates collagen production and tightens the skin from within. Many of our weight loss patients incorporate Morpheus8 treatments to address skin laxity on the face, neck, abdomen, or arms as they lose weight, helping them achieve smoother, firmer skin throughout the process.

By combining medical weight loss with targeted aesthetic treatments, you can achieve a comprehensive transformation that addresses both your health goals and your confidence.

What this costs at Femme

Prices are per treatment unless noted, and come straight from our pricing page. Member rates come through the membership program. How much product a result takes is settled at consultation — book one and we will quote you before anything begins.